Amrutanjan Health Care Ltd
Amrutanjan Health Care Ltd (AMRUTANJAN)

Amrutanjan Health Care Ltd (AMRUTANJAN)

₹8301.99%

Key Stats

₹810.1
Day's Price Range
₹834.9
₹656.25
52-Week Price Range
₹1024.55
1 Month Return3.23 %
3 Month Return-3.65 %
1 Year Return17.34 %

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

PE
Rank 296
EPS
Rank 300
BVPS
Rank 212
₹37.2
Dividend Yield
Rank 95
0.92%
ROE
Rank 32
32.64%
Price To Book Ratio
21.87
Debt To Asset
Rank 271
0.22

Company Information

The Madrasbased Amrutanjan manufactures bulk drugs and drug intermediateslike theophylline based on inhouse research. Three plants have been set up in the Alandur industrial belt near Madras to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones a type of agrochemicals at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops.Amrutanjan also has an agreement with a company in Philadelphia US to supply custommade chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill Amrutanjan gripe water sans alcohol Amrutanjan Maha Strong etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 199697 it has introduced a new product called Cold Snap Gel and also a mint called tingle. Company having two subsidiary companies viz. Amrutanjan Drugs Chemicals Ltd having holding stake 99.80 Amrutanjan Finance Ltd having holding stake is 57.26.Company has taken efforts to increase the export of fine chemicals also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover net Profit of the Company.Diakyur for the treatment of Diabetes was introduced during 20002001 and it has been well accepted by the customers. The companys R D has been engaged in the development of neutraceuticals.The company is mainly focussing on BioTech products and expects a good results from this division. During 200102 the company allotted 1600000 equity bonus shares of Rs.10/ each and subsequently the share capital has increased from Rs.1.60 crores to Rs.3.20 crores.
OrganisationAmrutanjan Health Care Ltd
HeadquartersChennai
IndustryPharmaceuticals